• Home
  • About Us
  • List of Health Insurance Companies

Health Plan News

Timely Health Plan News and Commmentary.

Health Plan News
Home Healthcare Plan News NRx Pharmaceuticals Provides Update on Breakthrough Therapy Designation (BTD) Request for ZYESAMI® (aviptadil)

NRx Pharmaceuticals Provides Update on Breakthrough Therapy Designation (BTD) Request for ZYESAMI® (aviptadil)

Posted on June 13, 2022 Written by Annalyn Frame

NRx Pharmaceuticals, Inc., (Nasdaq : NRXP, NRx Pharmaceuticals), a clinical-stage biopharmaceutical firm, announced today that the U.S. Food and Drug Administration denied the Breakthrough Therapy designation (BTD). The FDA denied ZYESAMI (r) (aviptadil). It emphasized the company’s NRX101 BTD compound for Bipolar Disorder associated with Suicidality and its NRX-101 BTD drug. Based on the positive findings of a subgroup analysis of patients treated with Aviptadil and placebo, and who had respiratory failure due to Critical COVID-19, the request for BTD was made.

“While we are disappointed by FDA’s decision, it was announced that our strategic focus has shifted to the advancement and designation of NRX-101 as Breakthrough Therapy. Topline data from our ongoing Phase II trial of NRX101 in bipolar depression and sub-acute suicide ideation (SSIB), should be available by the end this year. COVID-19 has unfortunately also led to a mental health crisis. This includes suicide attempts and depression. Robert Besthof, interim CEO at NRx Pharmaceuticals, stated that our commitment to patients with high unmet medical needs is still the heart of our work.

“ZYESAMI’s mechanism, well-characterized safety profile and the well-known safety profile of ZYESAMI, NRx Pharmaceuticals will continue to evaluate options for its use in high unmet pulmonary and other non-pulmonary indications.”

About NRx Pharmaceuticals
NRx Pharmaceuticals, Inc. (“NRx Pharmaceuticals” or the “Company”) draws upon decades of collective, scientific, and drug-development experience to address very high unmet needs of patients and bring improved health to patients. The U.S. Food and Drug Administration (“FDA”) has additionally granted Breakthrough Therapy designation, a Special Protocol Agreement, and a Biomarker Letter of Support for NRX-101, an investigational medicine for the treatment of severe bipolar depression in patients with acute suicidal ideation and behavior (ASIB) after initial stabilization with ketamine or other effective therapy. NRx Pharmaceuticals is led by executives who have held leadership roles at Lilly, Pfizer, and Novartis as well as major investment banking institutions.
Cautionary Note Regarding Forward-Looking Statements

This announcement of NRx Pharmaceuticals, Inc. includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995, which may include, but are not limited to, statements regarding our financial outlook, product development, business prospects, and market and industry trends and conditions, as well as the Company’s strategies, plans, objectives, and goals. These forward-looking statements are based on current beliefs, expectations, estimates, forecasts, and projections of, as well as assumptions made by, and information currently available to, the Company’s management.

The Company assumes no obligation to revise any forward-looking statement, whether as a result of new information, future events or otherwise. Accordingly, you should not place reliance on any forward-looking statement, and all forward-looking statements are herein qualified by reference to the cautionary statements set forth above.

Filed Under: Healthcare Plan News

Recent News

  • Numinus completes acquisition of Novamind June 13, 2022
  • NRx Pharmaceuticals Provides Update on Breakthrough Therapy Designation (BTD) Request for ZYESAMI® (aviptadil) June 13, 2022
  • King Insurance Acquires Wurzel Insurance June 13, 2022
  • Medicare Advantage Plans Earn High Marks in eHealth Survey June 13, 2022
  • Curated Mental Health Partners with Brooklyn Minds Psychiatry April 20, 2022
  • HEALTHWORXS: A Game Changer, No Cost Healthcare Plan April 20, 2022
  • Study Finds Consumers Want Their Physician to Lead April 20, 2022
  • Peer-Reviewed Journal Spotlights Lirio’s Approach to Behavioral Design and Its Ability to Impact Underserved Communities April 20, 2022
  • Braxia Scientific Provides Update on Clinical Trials for Ketamine and Psilocybin Drug Development February 8, 2022
  • Numinus Identified as a Licensed Psilocybin Supplier January 31, 2022

About Annalyn Frame

I am a nursing student currently, but have been interested in healthcare since I was much younger. It’s as if I have always known that I would eventually end up being a nurse or going into the healthcare industry.

I am the editor of Health Plan News.

Search Our Site

Ketamine Therapy Dallas
Ketamine Treatment Clinic Dallas

Categories

  • AARP
  • Aetna
  • AMERIGROUP
  • Blue Cross Blue Shield
  • Canadian Health Care System
  • Canadian Pharmacies
  • Cardinal Health
  • Chubb
  • CIGNA HealthCare
  • COVID-19
  • diabetes
  • Enterologics
  • Facilities And Providers
  • FDA
  • GlaxoSmithKline
  • Health Clinics
  • Health Insurance Coverage
  • Health Plan Enrollment
  • Healthcare Companies
  • Healthcare Plan News
  • HealthSouth
  • Home Care
  • Home Health Care Insurance
  • Hospitals
  • Humana
  • J.P. Morgan Healthcare Conference
  • Lidocaine
  • LifeTree eClinical
  • Lipitor
  • Liposuction
  • MedBasics
  • Medicaid
  • Medical And Healthcare
  • Medical Devices
  • Medicare
  • Mevion Medical Systems
  • Mobile Healthcare
  • Pharmaceutical Companies
  • Senior News
  • The SCOOTER Store
  • Thoracic Surgeons
  • thrombocytopenia
  • Today Sponge
  • Top Health Care Networks
  • Total Lumbar Fusion Graft Spine Surgery
  • Toxic Air Pollution
  • Trans Fats
  • Travel Insurance
  • Triglycerides
  • Tuberculosis
  • Unilife
  • United Healthcare
  • UnitedHealth Group
  • Unused Medications
  • Uterine fibroids
  • Vaccines
  • varicella
  • Ventas
  • Vyteris
  • WakeUpWalmart
  • Wal-Mart Healthcare Crisis
  • Walgreens Pharmacy
  • Water Quality
  • WebMD
  • WellPoint
  • West Nile Virus
  • Wilmer Shields Rich Awards
  • World Health Care Congress
  • Wound Management
  • Zelnorm
  • Zocor
  • ZOLOFT

Pages

  • 1199 National Benefit Fund
  • A Little about Drug Preparation and Formulation Development
  • About Us
  • Affordable Health Insurance
  • Benefits of Hiring a Senior Caregiving Service
  • Catastrophic Health Insurance
  • Cheap Health Insurance
  • Cheap Health Insurance Plans
  • Child Health Insurance Plans
  • Choosing a Health Insurance Plan
  • Christian Health Insurance
  • Dental Assistants and Their Future
  • Dr. Howard Bellin: Questions about Rhinoplasty
  • Finding the Right Dentist
  • Get Your Winks in Blink
  • Health Insurance
  • Health Insurance Plans For Family
  • Health Sharing Plans
  • Healthcare and Hospitals: Disinfection is Key
  • High Deductible Health Plans
  • Home Care Employment in Arizona
  • How A Medical Weight Loss Plan Can Help You Get The Figure You Want
  • How Ketamine Therapy Helps Fight Depression
  • How Orthotic Insoles Improve Your Health
  • Individual Health Insurance Plans
  • Ketamine Uses and Benefits
  • List of Health Insurance Companies
  • Low Income Health Insurance
  • Medical Research Consultants
  • Personal Lubricants for Women – Liven Up Your Life!
  • Private Health Insurance Plans
  • Rhesus Negative
  • Self Employed Health Insurance
  • Short Term Health Insurance Plans
  • Student Health Insurance Plans
  • Temporary Health Insurance
  • The Basic Building Blocks For a Sustained, Healthy Diet
  • The Importance of Clinical Study Software
  • The Use of Post Cycle Therapy Supplements
  • Travel Health Insurance

Copyright © 2022 · Focus Pro Theme on Genesis Framework · WordPress · Log in

Go to mobile version